Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

Following positive results from the Phase III CHEST-1 study in patients with inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH), the Phase IIIb CTEPH early access study (EAS) was designed to assess the safety and tolerability of riociguat in real-world clinical...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: McLaughlin, Vallerie V. (VerfasserIn) , Grünig, Ekkehard (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 28 December 2017
In: BMC pulmonary medicine
Year: 2017, Jahrgang: 17
ISSN:1471-2466
DOI:10.1186/s12890-017-0563-7
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1186/s12890-017-0563-7
Verlag, Volltext: https://doi.org/10.1186/s12890-017-0563-7
Volltext
Verfasserangaben:Vallerie V. McLaughlin, Pavel Jansa, Jens E. Nielsen-Kudsk, Michael Halank, Gérald Simonneau, Ekkehard Grünig, Silvia Ulrich, Stephan Rosenkranz, Miguel A. Gómez Sánchez, Tomás Pulido, Joanna Pepke-Zaba, Joan Albert Barberá, Marius M. Hoeper, Jean-Luc Vachiéry, Irene Lang, Francine Carvalho, Christian Meier, Katharina Mueller, Sylvia Nikkho and Andrea M. D’Armini

MARC

LEADER 00000caa a2200000 c 4500
001 1583782303
003 DE-627
005 20230427161317.0
007 cr uuu---uuuuu
008 181116s2017 xx |||||o 00| ||eng c
024 7 |a 10.1186/s12890-017-0563-7  |2 doi 
035 |a (DE-627)1583782303 
035 |a (DE-576)513782303 
035 |a (DE-599)BSZ513782303 
035 |a (OCoLC)1341023694 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a McLaughlin, Vallerie V.  |e VerfasserIn  |0 (DE-588)1171541740  |0 (DE-627)104062975X  |0 (DE-576)513783512  |4 aut 
245 1 0 |a Riociguat in patients with chronic thromboembolic pulmonary hypertension  |b results from an early access study  |c Vallerie V. McLaughlin, Pavel Jansa, Jens E. Nielsen-Kudsk, Michael Halank, Gérald Simonneau, Ekkehard Grünig, Silvia Ulrich, Stephan Rosenkranz, Miguel A. Gómez Sánchez, Tomás Pulido, Joanna Pepke-Zaba, Joan Albert Barberá, Marius M. Hoeper, Jean-Luc Vachiéry, Irene Lang, Francine Carvalho, Christian Meier, Katharina Mueller, Sylvia Nikkho and Andrea M. D’Armini 
264 1 |c 28 December 2017 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.11.2018 
520 |a Following positive results from the Phase III CHEST-1 study in patients with inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH), the Phase IIIb CTEPH early access study (EAS) was designed to assess the safety and tolerability of riociguat in real-world clinical practice, as well as to provide patients with early access to riociguat before launch. Riociguat is approved for the treatment of inoperable and persistent/recurrent CTEPH. 
700 1 |a Grünig, Ekkehard  |e VerfasserIn  |0 (DE-588)112535801  |0 (DE-627)618892605  |0 (DE-576)31856694X  |4 aut 
773 0 8 |i Enthalten in  |t BMC pulmonary medicine  |d London : BioMed Central, 2001  |g 17(2017), Artikel-ID 216  |h Online-Ressource  |w (DE-627)335489125  |w (DE-600)2059871-3  |w (DE-576)107015129  |x 1471-2466  |7 nnas  |a Riociguat in patients with chronic thromboembolic pulmonary hypertension results from an early access study 
773 1 8 |g volume:17  |g year:2017  |g elocationid:216  |g extent:9  |a Riociguat in patients with chronic thromboembolic pulmonary hypertension results from an early access study 
856 4 0 |u http://dx.doi.org/10.1186/s12890-017-0563-7  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://doi.org/10.1186/s12890-017-0563-7  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181116 
993 |a Article 
994 |a 2017 
998 |g 112535801  |a Grünig, Ekkehard  |m 112535801:Grünig, Ekkehard  |d 910000  |d 950000  |d 950900  |e 910000PG112535801  |e 950000PG112535801  |e 950900PG112535801  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 6 
999 |a KXP-PPN1583782303  |e 3032584140 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Vallerie V. McLaughlin, Pavel Jansa, Jens E. Nielsen-Kudsk, Michael Halank, Gérald Simonneau, Ekkehard Grünig, Silvia Ulrich, Stephan Rosenkranz, Miguel A. Gómez Sánchez, Tomás Pulido, Joanna Pepke-Zaba, Joan Albert Barberá, Marius M. Hoeper, Jean-Luc Vachiéry, Irene Lang, Francine Carvalho, Christian Meier, Katharina Mueller, Sylvia Nikkho and Andrea M. D’Armini"]},"recId":"1583782303","note":["Gesehen am 16.11.2018"],"person":[{"family":"McLaughlin","display":"McLaughlin, Vallerie V.","given":"Vallerie V.","role":"aut"},{"role":"aut","given":"Ekkehard","family":"Grünig","display":"Grünig, Ekkehard"}],"physDesc":[{"extent":"9 S."}],"title":[{"title_sort":"Riociguat in patients with chronic thromboembolic pulmonary hypertension","subtitle":"results from an early access study","title":"Riociguat in patients with chronic thromboembolic pulmonary hypertension"}],"relHost":[{"disp":"Riociguat in patients with chronic thromboembolic pulmonary hypertension results from an early access studyBMC pulmonary medicine","pubHistory":["1.2001 -"],"note":["Gesehen am 22. Mai 2020"],"recId":"335489125","type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"eki":["335489125"],"zdb":["2059871-3"],"issn":["1471-2466"]},"language":["eng"],"origin":[{"dateIssuedKey":"2001","publisher":"BioMed Central","publisherPlace":"London","dateIssuedDisp":"2001-"}],"title":[{"title":"BMC pulmonary medicine","title_sort":"BMC pulmonary medicine"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"17(2017), Artikel-ID 216","volume":"17","extent":"9","year":"2017"}}],"id":{"doi":["10.1186/s12890-017-0563-7"],"eki":["1583782303"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"origin":[{"dateIssuedDisp":"28 December 2017","dateIssuedKey":"2017"}]} 
SRT |a MCLAUGHLINRIOCIGUATI2820